论文部分内容阅读
目的:评价头孢噻利、头孢吡肟、头孢他啶治疗急性细菌感染的成本与效果。方法:将病例分为4组,A组246例用头孢噻利,B组256例用头孢吡肟(国产),C组257例用头孢吡肟(进口),D组246例用头孢他啶。平均剂量均为3g,平均疗程均为10日。结果:A、B、C、D组总成本分别为7506.6,794.1,4075.5,540元,总有效率分别为95.53%,94.14%,90.27%,93.09%,成本-效果比分别为78.58,8.44,45.15,5.8。结论:头孢他啶为4种治疗急性细菌感染方法中的最佳方案。
Objective: To evaluate the cost and effectiveness of ceftibride, cefepime and ceftazidime in the treatment of acute bacterial infections. Methods: The patients were divided into 4 groups: 246 patients in group A received ceftizone, 256 patients in group B received cefepime, 257 patients in group C received cefepime, and 246 patients in group D received ceftazidime. The average dose was 3g, the average course of treatment are 10 days. Results: The total cost of group A, B, C and D was 7506.6, 794.1 and 4075.5, 540 respectively. The total effective rates were 95.53%, 94.14%, 90.27% and 93.09% respectively, and the cost-effectiveness ratios were 78.58 and 8.44, 45.15,5.8. Conclusion: Ceftazidime is the best treatment for four acute bacterial infections.